C-reactive Protein and Carotid Intima-media Thickness in a Population of Middle-aged Koreans
![]() ![]() |
Suh, Min-A
(Department of Preventive Medicine, Yonsei University College of Medicine)
Lee, Joo-Young (Department of Preventive Medicine, Yonsei University College of Medicine) Ahn, Song-Vogue (Department of Preventive Medicine, Yonsei University College of Medicine) Kim, Hyeon-Chang (Department of Preventive Medicine, Yonsei University College of Medicine) Suh, Il (Department of Preventive Medicine, Yonsei University College of Medicine) |
1 | Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; Results from the Rotterdam study. Atherosclerosis 2007; 195(2): e195-202 DOI ScienceOn |
2 | Choi SH, Kim HC, Ahn CW, Cho HK, Cha BS, Chung YS, et al. Is high-sensitivity Creactive protein associated with carotic atherosclerosis in healthy Koreans? Eur J Cardiovasc Prev Rehabil 2005; 12(6): 548-554 DOI ScienceOn |
3 | Ryu SY, Lee YS, Park J, Kang MG, Kim KS. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci 2005; 20(3): 379-383 DOI ScienceOn |
4 | Ridker PM, Buring JE, Cook NR, Rifai N. Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8- year follow-up of 14179 initially healthy American women. Circulation 2003; 107(3): 391-397 DOI ScienceOn |
5 | Song HY, Song YS, Ahn CW, Kang SW, Choi KH, Ha SY, et al. Realationship between inflammatory markers and high resolution Bmode carotid artery ultrasono-graphy in continuous ambulatory peritoneal dialysis (CAPD) patients. Korean J Nephrol 2002; 21(2): 285-294. (Korean) |
6 | Hotamisiligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95(5): 2409-2415 DOI ScienceOn |
7 | Warren RS, Starnes HF, Gabrilove JL, Oettgen HF, Brennan MF. The acute metabolic effects of tumor necrosis factor administration in human. Arch Surg 1987; 122(12): 1396-1400 DOI ScienceOn |
8 | Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336(14): 973-979 DOI ScienceOn |
9 | Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmertz H. C-reactive protein and carotid intima media thickness in a community population. J Cardiovasc Risk 2002; 9(2): 97-103 DOI ScienceOn |
10 | Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media pro gression: The Carotid Atherosclerosis Progression Study. Stroke 2007; 38(6): 1774-1779 DOI ScienceOn |
11 | Kang ES, Kim HJ, Lee S, Kim HJ, Kim YM, Hur KY, et al. Serum high sensitivity Creactive protein is associated with carotid intima-media thickness, but not with microvascular complications in type 2 diabetes. Korean J Med 2003; 65(4): 443-450. (Korean) |
12 | Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342(12): 836-843 DOI ScienceOn |
13 | Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-1428 DOI ScienceOn |
14 | Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of Creactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study. Atheroscler Thromb Vasc Biol 2002; 22(10): 1662-1667 DOI ScienceOn |
15 | Son JC, Kim BT, Lee DJ, Choi HK, Chung HJ, Kim GM. The most associated risk factor of the metabolic syndrome with C-reactive protein. J Korean Soc Study Obes 2003; 12(1): 15-23. (Korean) |
16 | Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007; 99(11): 1598-1602 DOI ScienceOn |
17 | Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289(19): 2560-2572 DOI ScienceOn |
18 | Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomization study. Lancet 2005; 366(9468): 1954-1959 DOI ScienceOn |
19 | Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146(6): 483-494 PUBMED ScienceOn |
20 | Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of Creactive protein in Japanese adults and its association with cardiovascular risk factors: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 2007; 194(1): 238-244 DOI ScienceOn |
21 | World Health Organization Western Pacific Region, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications Australia; 2000 |
22 | Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-2497 DOI ScienceOn |
23 | Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16): 1685-1695 DOI PUBMED ScienceOn |
24 | Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem 2001; 47(3): 403-411 PUBMED ScienceOn |
25 | Pearson TA , Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3): 499-511 DOI ScienceOn |
26 | Ferranti SD, Rifai N. C-reactive protein: A nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 2007; 16(1): 14-21 DOI ScienceOn |
27 | Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S, Kuroda A, et al. Elevated C-reactive protein associated with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes care 2002; 25(8): 1432-1438 DOI ScienceOn |
28 | Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Athero sclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91(9): 2488-2496 DOI PUBMED ScienceOn |
![]() |